Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medicinova ( (MNOV) ) just unveiled an announcement.
MediciNova, Inc. held its 2025 annual meeting of stockholders on June 17, 2025, where several key proposals were voted upon. The meeting saw the election of Carolyn Beaver as a Class III Director, the ratification of BDO USA, P.C. as the independent accounting firm, approval of executive compensation, and a decision for stockholder advisory votes on executive compensation to occur every three years.
The most recent analyst rating on (MNOV) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Medicinova stock, see the MNOV Stock Forecast page.
More about Medicinova
Average Trading Volume: 12,859
Technical Sentiment Signal: Strong Sell
Current Market Cap: $65.23M
For an in-depth examination of MNOV stock, go to TipRanks’ Overview page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money